These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31120971)

  • 21. Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.
    Kubota Y; Folsom AR; Matsushita K; Couper D; Tang W
    Atherosclerosis; 2018 Jan; 268():225-230. PubMed ID: 29079449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function.
    Kim W; Moll M; Qiao D; Hobbs BD; Shrine N; Sakornsakolpat P; Tobin MD; Dudbridge F; Wain LV; Ladd-Acosta C; Chatterjee N; Silverman EK; Cho MH; Beaty TH
    JAMA Netw Open; 2021 Dec; 4(12):e2139525. PubMed ID: 34913977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening Tool for Restrictive and Obstructive Ventilatory Abnormalities in a Population-Based Survey.
    Fernandez-Plata R; Thirion-Romero I; Martinez-Briseño D; Franco-Marina F; Perez-Padilla R
    Rev Invest Clin; 2020 Dec; 72(6):386-393. PubMed ID: 33053574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
    Higbee DH; Granell R; Davey Smith G; Dodd JW
    Lancet Respir Med; 2022 Feb; 10(2):149-157. PubMed ID: 34739861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.
    Dharmage SC; Bui DS; Walters EH; Lowe AJ; Thompson B; Bowatte G; Thomas P; Garcia-Aymerich J; Jarvis D; Hamilton GS; Johns DP; Frith P; Senaratna CV; Idrose NS; Wood-Baker RR; Hopper J; Gurrin L; Erbas B; Washko GR; Faner R; Agusti A; Abramson MJ; Lodge CJ; Perret JL
    Lancet Respir Med; 2023 Mar; 11(3):273-282. PubMed ID: 36244396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.
    Miller MR; Haroon S; Jordan RE; Sitch AJ; Dickens AP; Enocson A; Fitzmaurice DA; Adab P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1979-1986. PubMed ID: 29950827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction.
    Fortis S; Corazalla EO; Jacobs DR; Kim HJ
    Respir Care; 2016 Sep; 61(9):1192-200. PubMed ID: 27165420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey.
    Pefura-Yone EW; Kengne AP; Balkissou AD; Magne-Fotso CG; Ngo-Yonga M; Boulleys-Nana JR; Efe-de-Melingui NR; Ndjeutcheu-Moualeu PI; Mbele-Onana CL; Kenmegne-Noumsi EC; Kolontchang-Yomi BL; Theubo-Kamgang BJ; Ebouki ER; Djuikam-Kamga CK; Amougou F; Mboumtou L; Petchou-Talla EL; Kuaban C;
    BMC Res Notes; 2016 Feb; 9():124. PubMed ID: 26917543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
    Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
    BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Chronic Obstructive Pulmonary Disease and its Associated Factors in Nepal: Findings from a Community-based Household Survey.
    Adhikari TB; Acharya P; Högman M; Neupane D; Karki A; Drews A; Cooper BG; Sigsgaard T; Kallestrup P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2319-2331. PubMed ID: 33061350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
    Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
    J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Respir Med; 2016 Nov; 120():1-9. PubMed ID: 27817804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results.
    Amaral AF; Coton S; Kato B; Tan WC; Studnicka M; Janson C; Gislason T; Mannino D; Bateman ED; Buist S; Burney PG;
    Eur Respir J; 2015 Oct; 46(4):1104-12. PubMed ID: 26113680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
    van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
    BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.